Muromachi ChemicalsMUROMACHI CHEMICALS INC.4885東証スタンダード医薬品FY ending May 2026, non-consolidated, J-GAAP
Out of every ¥100 of sales, about ¥9 is left as operating profit. Revenue changed +17.9% from the prior year, operating profit +71.9%.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | 8.0% | 1.18× | 9.5% | 2.87× | 27.3% |
| 2023 | 4.1% | 1.29× | 5.3% | 2.73× | 14.4% |
| 2024 | 5.2% | 1.27× | 6.6% | 2.46× | 16.2% |
| 2025 | 3.6% | 1.29× | 4.7% | 2.29× | 10.7% |
| 2026 | 2.1% | 1.35× | 2.8% | 2.46× | 6.9% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|
| Revenue | 5,681 | 6,291 | 6,369 | 6,653 | 7,841 |
| Cost of revenue | 3,948 | 4,539 | 4,514 | 4,693 | 5,483 |
| Gross profit | 1,733 | 1,752 | 1,855 | 1,960 | 2,358 |
| SG&A | 1,295 | 1,383 | 1,433 | 1,528 | 1,615 |
| Operating income | 437 | 369 | 422 | 432 | 743 |
| Pretax income | 426 | 351 | 469 | 350 | 328 |
| Income tax | -31 | 95 | 138 | 109 | 165 |
| Net income attributable to owners | 456 | 256 | 330 | 241 | 163 |
| Operating margin | 7.7% | 5.9% | 6.6% | 6.5% | 9.5% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending May 2022 | FY ending May 2023 | FY ending May 2024 | FY ending May 2025 | FY ending May 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥865.4M | ¥852.6M | ¥1.05B | ¥1.03B | ¥1.92B |
| Total assets | ¥4.8B | ¥4.95B | ¥5.06B | ¥5.26B | ¥6.35B |
| Net assets | ¥1.68B | ¥1.92B | ¥2.27B | ¥2.45B | ¥2.58B |
| Share capital | ¥143.2M | ¥143.2M | ¥143.2M | ¥143.2M | ¥143.2M |
| Property, plant and equipment | ¥908.1M | ¥911.9M | ¥1.06B | ¥1.11B | ¥748.2M |
| Intangible assets excluding goodwill | ¥40M | ¥69.8M | ¥64.6M | ¥53.2M | ¥42M |
| Investment securities | ¥44.1M | ¥100.9M | ¥277.4M | ¥301.4M | ¥430.7M |
| Current assets | ¥3.49B | ¥3.58B | ¥3.48B | ¥3.61B | ¥4.93B |
| Current liabilities | ¥2.23B | ¥2.06B | ¥1.59B | ¥1.46B | ¥2.46B |
| Short-term borrowings | ¥700M | ¥500M | ¥10M | — | — |
| Long-term borrowings | ¥783.1M | ¥872.2M | ¥1.1B | ¥1.24B | ¥1.2B |
| Total liabilities | ¥3.12B | ¥3.03B | ¥2.79B | ¥2.81B | ¥3.78B |
| Equity attributable to owners of parent | ¥1.67B | ¥1.9B | ¥2.17B | ¥2.34B | ¥2.38B |
| Retained earnings | ¥952M | ¥1.14B | ¥1.39B | ¥1.55B | ¥1.57B |
| Treasury stock | -¥109.8M | -¥49.9M | -¥35.9M | -¥27.6M | -¥21M |
EDINET (FSA Japan)
有価証券報告書－第80期(2025/06/01－2026/05/31)
EDINET (FSA Japan)
有価証券報告書－第79期(2024/06/01－2025/05/31)
EDINET (FSA Japan)
有価証券報告書－第78期(2023/06/01－2024/05/31)
EDINET (FSA Japan)
有価証券報告書－第77期(2022/06/01－2023/05/31)
EDINET (FSA Japan)
有価証券報告書－第76期(令和3年6月1日－令和4年5月31日)
EDINET (FSA Japan)
有価証券報告書－第75期(令和2年6月1日－令和3年5月31日)
Extracted from XBRL: 48 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.